About this trial

Obstructive sleep apnea (OSA) is a serious, chronic sleep-related breathing disease in which the upper airway repeatedly collapses during sleep, leading to intermittent oxygen deprivation. This pilot study will evaluate the Safety and Efficacy of Negative Pressure Neck Therapy (NPNT) in up to 10 healthy participants. Participants will undergo 2 separate home sleep apnea tests (HSAT) approximately 1 week apart and will be randomly assigned to wear the NPNT device at either night 1 or night 2 of HSAT. Participation will include 5 on-site visits and 1 phone call over approximately 1 month.

Eligibility criteria

Qualifiers

Body mass index ≤42 kg/m2

Able to speak, read, and write English

Disqualifiers

Known sleep disorder such as Obstructive Sleep Apnea (OSA), narcolepsy, restless leg syndrome, idiopathic hypersomnolence or chronic insomnia

No previous surgery, injury, or radiation to the neck

Excessive hair or beard in the area of the neck, and/or unwillingness to shave that area for the duration of this study

Inflammatory skin condition, such as acne or eczema in the neck area

Trial design

Treatments tested in this trial

  • Negative Pressure Neck Therapy (NPNT)

Treatment groups

10 Participants
are divided into 2 treatment groups

Locations

2
Centre for Lung HealthV5Z 1M9, VancouverBritish Columbia, Canada
Leon Judah Blackmore Centre for Sleep DisordersV6T 2B5, VancouverBritish Columbia, Canada

Sponsors and collaborators

University of British Columbia

Lead sponsor

Vancouver Coastal Health Research Institute

Collaborator